Participation of ATM in insulin signalling through phosphorylation of elF-4E-binding protein 1

Nature Cell Biology

Volumn 2, Issue 12, 2000, Pages 893-898

  Yang, D Q ^a   Kastan, M B ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GENE PRODUCT; INITIATION FACTOR; INSULIN; PHOSPHOTRANSFERASE;

ANIMAL CELL; ARTICLE; ATAXIA TELANGIECTASIA; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSLATION INITIATION;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ATAXIA TELANGIECTASIA; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DNA-BINDING PROTEINS; EUKARYOTIC INITIATION FACTOR-4E; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; MODELS, BIOLOGICAL; PEPTIDE INITIATION FACTORS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SERINE; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0033662156     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35046542     Document Type: Article

References (50)

1. The role of ATM in DNA damage responses and cancer
2. The genetic defect in ataxia-telangiectasia
3. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice
4. Atm deficient mice: A paradigm of ataxia telangiectasia
5. Extreme insulin resistance in ataxia telangiectasia: Defect in affinity of insulin receptors
6. An unusual form of diabetes mellitus in ataxia telangiectasia
7. Insulin-resistant diabetes mellitus in a black woman with ataxia-telangiectasia
8. p53 and ATM: Cell cycle, cell death, and cancer
9. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
10. Dual roles of ATM in the cellular response to radiation and in cell growth control
11. Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism
12. Growth of cultured cells from patients with ataxia-talangiectasia
13. TOR signalling and control of cell growth
14. A signaling pathway to translational control
15. A single ataxia telangiectasia gene with a product similar to PI-3 kinase
16. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
17. Enhanced phosphorylation of p53 by ATM in response to DNA damage
18. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks
19. 2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity
20. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway
21. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin
22. Purification and characterization of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase
23. Regulation of 4E-BP1 phosphorylation: A novel two-step mechanism
24. Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR
25. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1
26. Regulation of elF-4E BP1 phosphorylation by mTOR
27. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin
28. PHAS-1 as a link between mitogen-activated protein kinase and translation initiation
29. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function
30. The mRNA 5' cap-binding protein eIF4E and control of cell growth
31. PHAS/4E-BPs as regulators of mRNA translation and cell proliferation
32. Molecular mechanisms for the control of translation by insulin
33. Substrate specificities and identification of putative substrates of ATM kinase family members
34. Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor 4E-binding protein 1 on the raparaycin-insensitive site (serine-111)
35. Control of p70 s6 kinase by kinase activity of FRAP in vivo
36. Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells
37. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation
38. Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression
39. Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes
40. Phosphorylation of the translational regulator, PHAS-I, by protein kinase CK2
41. Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints
42. The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage
43. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells
44. ATM binds to beta-adaptin in cytoplasmic vesicles
45. Localization of a portion of extranuclear ATM to peroxisomes
46. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation
47. ATM deficiency results in severe meiotic disruption as early as leptonema of prophase I
48. Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development
49. Rapamycin-resistant phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in v-SRC-transformed hamster fibroblasts
50. 4E-BP3, a new member of the eukaryotic initiation factor 4E-binding protein family